A Prospective Cohort Study to Assess Clinical Effectiveness of an Investigational Digital Therapeutic (CT-155) in Patients With Experiential Negative Symptoms of Schizophrenia
Public ClinicalTrials.gov record NCT06791122. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Pragmatic Study to Evaluate Clinical Effectiveness, Engagement With the Study App, Healthcare Resource Utilization, and Safety of an Investigational Digital Therapeutic (CT-155) in Patients With Experiential Negative Symptoms of Schizophrenia
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study is open to people aged 18 years or older with schizophrenia. People can join the study if they are willing to use a smartphone app called CT-155. This app is being developed to help people with schizophrenia manage their negative symptoms. The purpose of this study is to gather new information on CT-155. Researchers want to see how well it works, how well participants use the study app, and how it affects the use of health care services. Participants use the app for 16 weeks. They may continue using it for another 16 weeks. During the study, participants continue with their normal treatment for schizophrenia. Participants are in the study for about a year. During this time, they visit the study site every 2 months. During this study, doctors regularly check participants' schizophrenia symptoms and overall quality of life. Researchers may also compare the healthcare data of study participants with a similar group of people with schizophrenia who are not part of the study. The doctors also regularly check participants' health and take note of any unwanted effects.
Study identification
- NCT ID
- NCT06791122
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 262 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 23, 2025 (Actual)
- Primary completion
- Aug 24, 2026 (Actual)
- Completion
- Aug 24, 2026 (Actual)
- Last update posted
- Sep 9, 2026
2025 – 2026
United States locations
- U.S. sites
- 31
- U.S. states
- 15
- U.S. cities
- 28
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Sun Valley Behavioral Med Center | Imperial | California | 92251 | — |
| University of California San Diego | La Jolla | California | 92093 | — |
| North Country Clinical Research, Inc. | Oceanside | California | 92054 | — |
| ATP Clinical Research, Inc. | Orange | California | 92866 | — |
| NRC Research Institute | Orange | California | 92868 | — |
| Stanford University School of Medicine | Stanford | California | 94305 | — |
| Collaborative Neuroscience Research, LLC | Torrance | California | 90504 | — |
| CT Clinical Research | Cromwell | Connecticut | 06416 | — |
| Galiz Research | Hialeah | Florida | 33106 | — |
| New Life Medical Research Center, Inc. | Hialeah | Florida | 88012 | — |
| University of Miami | Miami | Florida | 33136 | — |
| Global Life Research Network | Miami | Florida | 33155 | — |
| Interventional Psychiatry of Tampa Bay Clinical Research | Tampa | Florida | 33629 | — |
| Health Synergy Clinical Research, LLC | West Palm Beach | Florida | 33407 | — |
| Emory University | Atlanta | Georgia | 30303 | — |
| Sheppard Pratt | Baltimore | Maryland | 21204 | — |
| CBH Health, LLC | Gaithersburg | Maryland | 20877 | — |
| Boston Neurobehavioral Associates | Brookline | Massachusetts | 02446 | — |
| UMass Chan Medical School | Worcester | Massachusetts | 01655 | — |
| Western Michigan University Homer Stryker M.D. School of Medicine | Kalamazoo | Michigan | 49048 | — |
| St. Charles Psychiatric Associates - Midwest Research Group | Saint Charles | Missouri | 63304 | — |
| IMA Clinical Research Las Vegas | Las Vegas | Nevada | 89102 | — |
| Neurobehavioral Research, Inc. | Cedarhurst | New York | 11516 | — |
| Richmond Behavioral Associates | Staten Island | New York | 10314 | — |
| Atrium Health Behavioral Health Digital Therapy | Charlotte | North Carolina | 28211 | — |
| Rivus Wellness and Research Institute | Oklahoma City | Oklahoma | 73112 | — |
| Psychiatric Consultants, PC | Franklin | Tennessee | 37067 | — |
| Beaumont Psychiatry Clinic | Beaumont | Texas | 77706 | — |
| Red Oak Psychiatry Associates, PA | Houston | Texas | 77090 | — |
| SMS Clinical Research, LLC | Mesquite | Texas | 75149 | — |
| Salem VA Medical Center | Salem | Virginia | 24153 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06791122, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 9, 2026 · Synced Oct 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT06791122 live on ClinicalTrials.gov.